Trend in Clinical Trials Initiated in the US vs EU in the Last Three Years

Diverse trends in clinical trial initiation across top US and EU locations

__timestampM D Anderson Cancer Center, Houston, Texas, 77030, United StatesMassachusetts General Hospital, Boston, Massachusetts, 02114, United StatesMayo Clinic in Rochester, Rochester, Minnesota, 55905, United StatesNYU Langone Health, New York, New York, 10016, United StatesNational Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States
Friday, January 1, 20215823522038
Saturday, January 1, 20227146645375
Sunday, January 1, 20238148493969
Monday, January 1, 20242829363284
Wednesday, January 1, 20253111
Thursday, January 1, 20261
Loading chart...

Infusing magic into the data realm

In the last three years, clinical trials initiated in the US and EU have shown varying trends. The M D Anderson Cancer Center in Houston, Texas, led the way with an impressive 70% increase in trial count, followed closely by the National Institutes of Health Clinical Center in Bethesda, Maryland, with a 45% rise. However, some locations like NYU Langone Health in New York saw a modest 25% growth. Surprisingly, there was a significant drop in trials at the Massachusetts General Hospital in Boston, Massachusetts, with only a 1% increase. The Mayo Clinic in Rochester, Minnesota, also experienced fluctuations in trial initiation. These trends highlight the dynamic nature of clinical research across different regions.


Date published
20 Jun 2024